Navigation Links
Pharmexa in Medical Technology

Pharmexa A/S (DK) - Pharmexa presents data from influenza program

Summary: Pharmexa-Epimmune, the U.S.-based subsidiary of Pharmexa A/S, presents selected data from its influenza vaccine program today at the Influenza Conference entitled, "Options for the Control of Influenza VI," held in Toronto, Ontario, Canada. The data show that a "universal" vaccine designe...

Positive Results Using Affitech-Identified Human Antibody That Blocks VEGF Binding to VEGF Receptor 2 in Preclinical Cancer Model Reported by Peregrine

...with low royalty stacking. The Company has concluded deals with commercial organizations such as Peregrine, XOMA, NatImmune, Viventia, Dyax, Micromet, pharmexa and others. Further information at www.affitech.com. Contact Affitech (Norway) Dr. Martin Welschof Chief Executive Officer +47 22 95 87 58 <...

Pharmexa A/S (DK) - Long lasting immune response and survival to RAS vaccine

...f Executive Officer, telephone +45 4516 2525 Claude Mikkelsen, Head of Investor Relations, telephone +45 4516 2525 or +45 4060 2558 Note to editors: pharmexa A/S is a leading company in the field of active immunotherapy and vaccines for the treatment of cancer, serious chronic and infectious diseases. Pharm...
Pharmexa in Biological Technology

Peregrine Pharmaceuticals Licenses Anti-VEGF Antibodies to Affitech

... Affitech A/S is an antibody research and development company. It was formed recently by a reverse merger of Norway, Oslo-based Affitech AS with pharmexa A/S, a Danish biotech company. The merged company has developed several proprietary technology platforms that constitute a highly productive, fully h...

Pharmexa and Affitech to Combine Operations to Create a New Antibody Therapeutics Company

... COPENHAGEN and OSLO, March 4 /PRNewswire/ -- pharmexa A/S and Affitech AS announced today that they have...anies by means of a share for share acquisition by pharmexa A/S of the private Norwegian company, Affitech AS. The purpose of the merger is to transform pharmexa from a cancer and infectious disease vaccine busin...

Affitech Acquires Pharmexa's Diabody Technology

...ndidates for a variety of therapeutic applications. The acquisition follows an exclusive license of the diabody IP that Affitech obtained in 2007 from pharmexa to carry out certain non-clinical GLP compliant studies, as well as sub-licensing arrangements with third parties. Affitech CEO Martin Welschof comm...

Affitech Announces Second Milestone in Roche Antibody Discovery Collaboration

...y stacking. The Company has concluded deals with commercial organizations such as Omeros, Roche, Peregrine, XOMA, NatImmune, Viventia, Dyax, Micromet, pharmexa and others. Further information at http://www.affitech.com . Contacts for Affitech: Affitech (Norway): Dr. Martin Welschof Chief Executive Off...

Affitech Appoints Dr. Keith McCullagh as Chairman

...y stacking. The Company has concluded deals with commercial organizations such as Roche, Peregrine, Omeros, XOMA, NatImmune, Viventia, Dyax, Micromet, pharmexa and others. Further information at http://www.affitech.com . About Keith McCullagh Keith McCullagh, PhD, BVSc, MRCVS, is an experienced bioscienc...

Emergence of Cancer Vaccines Will Be the Key Factor Driving the Pancreatic Cancer Drug Market to More Than Double by 2016

...orld's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the emergence of cancer vaccines, including drugs from pharmexa and Cell Genesys, will be the key factor driving the pancreatic cancer drug market to more than double by 2016. The new Pharmacor report entitled Pan...
Other Tags
(Date:5/22/2013)... 2013 Following the success of last ... Fit Body Boot Camp Kincardine has announced it ... Challenge starting on June 3rd at its Kincardine ... Street, Kincardine, Ontario.     , Fit Body Boot Camp’s 1,000 ... local community residents to lose a total of 1,000 ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 LDM Global ... discovery management services for law firms, corporations and government ... Inc., a cloud-based e-discovery software company, to deliver defensible ... newly formed partnership, Cumulus Data and LDM Global hosted ... LA on Tuesday, May 21st. This event was ...
(Date:5/22/2013)... City, NJ (PRWEB) May 22, 2013 ... compliance, and management solutions for social enterprise collaboration ... LLC, a consulting firm based in Chicago, Ill. ... integrate their products and provide best-in-class solutions for ... and improve collaboration. , AvePoint’s DocAve Software ...
(Date:5/22/2013)... May 22, 2013 Asthma, a disorder ... and swell causes wheezing, shortness of breath, chest tightness ... occurs, the muscles surrounding the airways become tight and ... amount of air that can pass. Asthma attacks can ... airflow is severely restricted. Reuters reports that ...
(Date:5/22/2013)... Poor adherence to appropriate medication therapy has been ... death (some 125,000 deaths in the U.S. every year ... It’s been estimated that between 33% and 69% of ... adherence — a reality that costs the American health-care ... is the degree of medication non-adherence — and the ...
Breaking Medicine News(10 mins):Health News:Kincardine Fitness Center Promotes 2nd Annual 1,000 lb. Meltdown Challenge to Fight Obesity With All Proceeds Raised Going to Local Charity 2Health News:Kincardine Fitness Center Promotes 2nd Annual 1,000 lb. Meltdown Challenge to Fight Obesity With All Proceeds Raised Going to Local Charity 3Health News:LDM Global Enhances Forensic Data Collection Services with eCloudCollect 2Health News:LDM Global Enhances Forensic Data Collection Services with eCloudCollect 3Health News:AvePoint Teams with Tahoe Partners, LLC to Enrich Microsoft SharePoint Deployments and Improve Collaboration 2Health News:AvePoint Teams with Tahoe Partners, LLC to Enrich Microsoft SharePoint Deployments and Improve Collaboration 3Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announce New hCG Diet Plans That May Reduce the Severity of Asthma Attacks 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announce New hCG Diet Plans That May Reduce the Severity of Asthma Attacks 3Health News:Patient Prompt® Announces New Drug Adherence Program to Assist in Prescribed Medication Compliance 2
(Date:5/21/2013)... , May 21, 2013 Royal Philips Electronics ... the world,s first portable ultrasound with Philips, industry leading ... capability. The CX50 xMATRIX with available Live 3D TEE ... at the EuroPCR, official meeting for the ... Since its launch in 2012, Philips CX50 ...
(Date:5/20/2013)... also commonly resistant to antimicrobial substances made by ... mBio , the online open-access journal of ... and host antimicrobials LL-37 and lysozyme, which help ... that patients with life-threatening multi-drug resistant infections are ... is a last-line drug for treating several kinds ...
(Date:5/20/2013)... the effect of physical education (PE) on child weight, ... increasing the amount of time that elementary schoolchildren spent ... The study represents some of the first evidence of ... is forthcoming in the Journal of Health Economics ... can be viewed at: http://www.sciencedirect.com/science/article/pii/S0167629613000556 , The ...
Breaking Biology News(10 mins):Philips CX50 xMATRIX now offers world-class interventional and diagnostic features on single portable system 2Resistance to last-line antibiotic makes bacteria resistant to immune system 2Resistance to last-line antibiotic makes bacteria resistant to immune system 3Gym class reduces probability of obesity, study finds for first time 2
Other Contents